Key statistics
As of last trade, Pharming Group NV (PHG:FRA) traded at 7.05, 17.50% above the 52 week low of 6.00 set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.10 |
---|---|
High | 7.10 |
Low | 7.05 |
Bid | 7.05 |
Offer | 7.90 |
Previous close | 7.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 15 2024 14:29 GMT.
More ▼
Announcements
- Pharming Group to participate in November investor conference
- Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
- Pharming Group reports third quarter 2024 financial results and provides business update
- Pharming Group to report third quarter 2024 financial results on October 24
- Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
- Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
- Pharming Group to participate in September investor conferences
- Pharming Group reports second quarter and first half 2024 financial results and provides business update
- Pharming Group to report second quarter and first half 2024 financial results on August 1
- Pharming Group to participate in June investor conferences
More ▼